Evaluation of the transition from intravenous to subcutaneous vedolizumab in patients with inflammatory bowel disease Carmen Amor Costa; Cristina Suárez Ferrer; Laura García Ramírez; Eduardo Martín-Arranz; Joaquín Poza Cordón; José Luis Rueda García; María Sánchez Azofra; Irene González Diaz; Clara Amiama Roig; María Dolores Martín-Arranz;

Thromboembolic phenomena in inflammatory bowel disease and risk with JAK inhibitor treatments José Luis Rueda García; José Manuel Benitez; Iria Baston Rey; Margalida Calafat Sard; Cristina Suárez Ferrer;

Efficacy and safety of biological treatment for inflammatory bowel disease in elderly patients: Results from a GETECCU cohort Cristina Suárez Ferrer; Francisco Mesonero Gismero; Berta Caballol; Maria Pilar Ballester; Iria Bastón Rey; Andrés Castaño García; Jose Miranda Bautista; Rosa Saiz Chumillas; Jose Manuel Benitez; Laura Sanchez-Delgado; Alicia López-García; Cristina Rubin de Celix; Inmaculada Alonso Abreu; Luigi Melcarne; Rocío Plaza Santos; Miquel Marques-Camí; Antonio Caballero Mateos; César Gómez Díez; Margalida Calafat; Horacio Alonso Galan; Pablo Vega Vilaamil; Beatriz Castro Senosiain; Andrea Guerro Moya; Carmen Yolanda Rodriguez Diaz; Katerina Spicakova; Noemi Manceñido Marcos; Gema Molina; Luisa de Castro Parga; Andres Rodriguez Angulo; Lidia Cuevas del Campo; Maria del Carmen Rodriguez Grau; Fernando Ramirez; Barbara Gomez Pastrana; Irene Gonzalez Partida; Belen Botella Mateu; Elena Peña Gonzalez; Eduardo Iyo; Alfonso Elosua Gonzalez; Empar Sainz Arnau; Luis Hernandez Villalba; Pablo Perez Galindo; Leyanira Torrealba Medina; Sara Monsalve Alonso; Jose Antonio Olmos Perez; Carmen Dueñas Sadornil; Laura Garcia Ramirez; María Dolores Martín-Arranz; Antonio López Sanroman; Agnès Fernández; Victor Merino Murgui; Cristina Calviño Suárez; Pablo Flórez-Diez; María Elena Lobato Matilla; Beatriz Sicilia; Pilar Soto Escribano; Carlos Maroto Martin; Míriam Mañosa; Manuel Barreiro-De Acosta;